« Previous AbstractGraphite microparticles as coatings for quartz crystal microbalance-based gas sensors    Next AbstractA modern purification method for volatile sesquiterpenes produced by recombinant Escherichia coli carrying terpene synthase genes »

Paediatr Respir Rev

Title:		Electronic cigarettes and e-cigarette/vaping product use associated lung injury (EVALI)
Author(s):		Shinbashi M; Rubin BK;
Address:		"Virginia Commonwealth University, Department of Pediatrics and the Children's Hospital of Richmond at VCU, Richmond, VA, United States. Virginia Commonwealth University, Department of Pediatrics and the Children's Hospital of Richmond at VCU, Richmond, VA, United States. Electronic address: brubin@vcu.edu"
Journal Title:		Paediatr Respir Rev
Year:		2020
Volume:		20200611
Issue:
Page Number:		87 - 91
DOI:		10.1016/j.prrv.2020.06.003
ISSN/ISBN:		1526-0550 (Electronic) 1526-0542 (Linking)
Abstract:		"Electronic cigarettes (e-cigarettes) are noncombustible tobacco products that have been promoted as safer alternatives to conventional cigarettes and beneficial tools for smoking cessation. However, e-cigarettes have been shown to produce aerosols with high concentrations of propylene glycol, glycerol, volatile organic compounds, and free radicals, which can lead to lung damage. Furthermore, e-cigarettes can deliver nicotine at concentrations higher than traditional combustibles, making them highly addictive. As delivery devices became smaller, less expensive, and refillable, the use of e-cigarettes dramatically increased, especially among adolescents and young adults in the United States. This rise in popularity of noncombustible products led to an outbreak of e-cigarette or vaping product use-associated lung injury (EVALI) in the fall of 2019. In this article, we review the history of e-cigarettes and its prevalence among American youth, the EVALI outbreak and clinical presentation of EVALI patients, and recent legislative efforts to regulate e-cigarette use"
Keywords:		Acute Lung Injury/*epidemiology/etiology/physiopathology Adolescent Cannabidiol/administration & dosage Cannabinoid Receptor Agonists/administration & dosage Child Disease Outbreaks Dronabinol/administration & dosage E-Cigarette Vapor/adverse effects/chem;
Notes:		"MedlineShinbashi, Meagan Rubin, Bruce K eng Review England 2020/07/13 Paediatr Respir Rev. 2020 Nov; 36:87-91. doi: 10.1016/j.prrv.2020.06.003. Epub 2020 Jun 11"